APA

Domchek S. M., Aghajanian C., Shapira-Frommer R., Schmutzler R. K., Audeh M. W., Friedlander M., Balmaña J., Mitchell G., Fried G., Stemmer S. M., Hubert A., Rosengarten O., Loman N., Robertson J. D., Mann H. & Kaufman B. (20160601). Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy. : Gynecologic oncology.

Chicago

Domchek Susan M, Aghajanian Carol, Shapira-Frommer Ronnie, Schmutzler Rita K, Audeh M William, Friedlander Michael, Balmaña Judith, Mitchell Gillian, Fried Georgeta, Stemmer Salomon M, Hubert Ayala, Rosengarten Ora, Loman Niklas, Robertson Jane D, Mann Helen and Kaufman Bella. 20160601. Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy. : Gynecologic oncology.

Harvard

Domchek S. M., Aghajanian C., Shapira-Frommer R., Schmutzler R. K., Audeh M. W., Friedlander M., Balmaña J., Mitchell G., Fried G., Stemmer S. M., Hubert A., Rosengarten O., Loman N., Robertson J. D., Mann H. and Kaufman B. (20160601). Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy. : Gynecologic oncology.

MLA

Domchek Susan M, Aghajanian Carol, Shapira-Frommer Ronnie, Schmutzler Rita K, Audeh M William, Friedlander Michael, Balmaña Judith, Mitchell Gillian, Fried Georgeta, Stemmer Salomon M, Hubert Ayala, Rosengarten Ora, Loman Niklas, Robertson Jane D, Mann Helen and Kaufman Bella. Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy. : Gynecologic oncology. 20160601.